NEERJESH P; RAJKISHOR SINGH; VIPENDER SINGH CHOPRA; DHARTI N; KAVITA DHAR; SANJAY KUMAR SINGH. Would other oral hypoglycaemics persist as an adequate 1ST line add-on therapy to metformin in patients with type 2 diabetes mellitus? No, it’s time to refocus!. World Journal of Pharmaceutical Sciences, [S. l.], v. 3, n. 12, p. 2444–2451, 2015. Disponível em: https://www.wjpsonline.com/index.php/wjps/article/view/oral-hypoglycaemics-metformin-diabetes-mellitus. Acesso em: 28 jun. 2025.